Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Versant Venture Management, Llc > Profile

Instuitional Investor - Versant Venture Management, Llc

Fund Profile
Filing Period:
Fund Name: Versant Venture Management, Llc
Portfolio Value $82,136,885
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Monte Rosa Therapeutics Inc.
 GLUE 5,652,922 $25,494,678 31.04%
2.
Crispr Therapeutics Ag
 CRSP 498,558 $24,249,861 29.52%
3.
Jade Biosciences Inc.
 JBIO 1,525,820 $15,242,942 18.56%
4.
Skye Bioscience Inc.
 2,007,704 $8,392,203 10.22%
5.
Repare Therapeutics Inc.
 RPTX 2,646,657 $3,678,853 4.48%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)